# FTIH - Single and Repeat Oral Doses of FDL169 in Healthy Volunteers

> **NCT02359357** · PHASE1 · COMPLETED · sponsor: **Flatley Discovery Lab LLC** · enrollment: 130 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** FDL169
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02359357
- **Lead sponsor:** Flatley Discovery Lab LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2016-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02359357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02359357, "FTIH - Single and Repeat Oral Doses of FDL169 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02359357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*